Editorial

Personalised Cancer Vaccines Show Longer-Term Staying Power

Europe: the EU Cardiovascular Health Plan is becoming the “cancer plan” moment for heart disease

A new Lp(a) threshold could reshape cardiovascular risk assessment

The next cardiometabolic battleground is ultra-processed food

ADA 2026 findings show diabetes drugs are no longer just chasing glucose

Oral SERDs Face the Hard Test: Where Do They Actually Fit?

Prostate Cancer Value Starts Counting Cognition

China’s PD-1/VEGF Bet Challenges the Lung Cancer Backbone

The ASCO Drug Race Still Runs Through Genomic Testing
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
